ELIZABETH CHAVARRIA: Open Payments
NPI 1346079886 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $279 |
| Lilly USA, LLC | 7 | $184 |
| Phathom Pharmaceuticals, Inc. | 1 | $78 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Ozempic, ZEPBOUND, VOQUEZNA, MOUNJARO, Wegovy, TZIELD, CAPVAXIVE, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
